How head and neck squamous cell carcinomas take over wound-healing processes

November 29, 2017, Agency for Science, Technology and Research (A*STAR), Singapore
How head and neck squamous cell carcinomas take over wound-healing processes
Elevated expression of DIAPH1 protein (shown in red) in a squamous cell carcinoma patient. Credit: A*STAR Institute of Medical Biology

A*STAR researchers have identified the molecular means by which a common form of cancer hijacks wound-healing processes to help it spread. The team hope their findings could lead to more effective treatments.

Head and neck (HNSCC) is the sixth most frequently-occurring cancer worldwide. It is caused by the uncontrolled growth of squamous —thin, flat, scale-like cells—in the outer layer of skin called the epidermis.

Upon injury, epidermal cells called keratinocytes proliferate and migrate toward wounds, a process that normally stops when healing is complete. In 2013, Prabha Sampath's group at the A*STAR Institute of Medical Biology discovered a that triggers the production of a microRNA called miR-198 in healthy skin, and, upon injury, of the protein follistatin-like 1 (FSTL-1).

Given that and migration are hallmarks of cancer and a primary cause for metastasis, Sampath's team set out to test their hypothesis that a defective wound-healing switch could facilitate HNSCC.

They used a technique called fluorescent in situ hybridization to show that miR-198 was expressed in abundance in tongue cells from healthy patients, but absent from those from HNSCC patients. Their finding of elevated FSTL1 expression in HNSCC samples suggested the molecular switch was indeed defective. In the absence of miR-198, they also found increased expression of Diaphanous-1 (DIAPH1), another protein elevated following skin wounding.

Using biochemical and cell culture experiments, the researchers went on to show that a protein that triggers cell growth and differentiation called (EGF), which is often elevated in HNSCC, acts as a regulator of the defective switch. They revealed the precise molecular mechanism involved.

Sampath's group further showed that blocking FSTL1 and DIAPH1 individually not only thwarts the ability of HNSCC cancer cells to migrate, but also limits the spread of metastatic tumors in immunodeficient mice. Notably, knocking out both genes simultaneously prevented formation of metastatic tumor nodules. Analysis of The Cancer Genome Atlas (TCGA) data base showed the survival of HNSCC patients who expressed elevated levels of both FSTL1 and DIAPH1 was significantly shorter than those who expressed them at lower levels.

Further investigation revealed FSTL1 and DIAPH1 promote HNSCC metastasis by blocking the actions of other proteins that normally prevent cell migration.

The findings provide new targets for therapeutic intervention. "Additionally, we are trying to identify biochemical modulators of this defective molecular which could serve as novel and alternative drugs to effectively treat this deadly disease," says Sampath.

Explore further: Scientists discover 'switch' critical to wound healing

More information: Gopinath M. Sundaram et al. EGF hijacks miR-198/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis, The Journal of Experimental Medicine (2017). DOI: 10.1084/jem.20170354

Related Stories

Scientists discover 'switch' critical to wound healing

March 8, 2013
Patients with diseases such as diabetes suffer from painful wounds that take a long time to heal, making them more susceptible to infections that could even lead to amputations. A*STAR's discovery paves the way for therapeutics ...

Researchers ID potential prognostic marker for recurrence of head and neck squamous cell carcinoma

March 20, 2015
A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated ...

High CVD risk in patients with head, neck squamous cell cancer

February 2, 2017
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published ...

Sensitizing tumor cells to radiotherapy

March 1, 2012
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide. Tumor resistance to radio- and/or chemotherapy remains a significant clinical problem.

Targeting cancer stem cells improves treatment effectiveness and prevents metastasis

March 9, 2017
Targeting cancer stem cells may be a more effective way to overcome cancer resistance and prevent the spread of squamous cell carcinoma—the most common head and neck cancer and the second-most common skin cancer, according ...

Recommended for you

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

Aggressive breast cancer already has resistant tumour cells prior to chemotherapy

April 20, 2018
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.